These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8477201)

  • 21. Antineutrophil antibodies in vasculitis.
    Savage CO; Lockwood CM
    Adv Nephrol Necker Hosp; 1990; 19():225-36. PubMed ID: 2105580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic vasculitis and myelodysplasia.
    Warren AJ; Hegde UM; Nathwani A; Reilly IA
    Br J Haematol; 1990 Aug; 75(4):627-9. PubMed ID: 2207019
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia.
    Browning CE; Dixon JE; Malone JC; Callen JP
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S135-8. PubMed ID: 16021163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic vasculitis positive for circulating anti-neutrophil cytoplasmic antibodies and with predominantly neurological presentation.
    Stumvoll M; Schnauder G; Overkamp D; Buettner UW; Grodd W; Eggstein M
    Clin Investig; 1993 Aug; 71(8):613-5. PubMed ID: 8219655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of Sweet's syndrome and myelodysplasia: response to cyclosporin.
    Sharpe GR; Leggat HM
    Br J Dermatol; 1992 Nov; 127(5):538-9. PubMed ID: 1467297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of abdominal large-vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5-azacytidine in a patient with myelodysplastic syndrome.
    Kawano H; Suzuki T; Ishii S; Wakahashi K; Kawano Y; Sada A; Minagawa K; Ueno D; Yamasaki T; Itoh T; Yokozaki H; Katayama Y
    Eur J Haematol; 2014 Apr; 92(4):362-4. PubMed ID: 24341928
    [No Abstract]   [Full Text] [Related]  

  • 28. The antigenic significance and methods of detection of the anti-neutrophil cytoplasmic autoantibodies (ANCA).
    Bosch X; Asherson RA
    Postgrad Med J; 1992 Sep; 68(803):707-13. PubMed ID: 1480534
    [No Abstract]   [Full Text] [Related]  

  • 29. Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet's Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils.
    Passet M; Lepelletier C; Vignon-Pennamen MD; Chasset F; Hirsch P; Battistella M; Duriez P; Sicre de Fontbrune F; Boissel N; Legrand O; Raffoux E; Bagot M; Adès L; Clappier E; Bouaziz JD
    J Invest Dermatol; 2020 Sep; 140(9):1873-1876.e5. PubMed ID: 32081610
    [No Abstract]   [Full Text] [Related]  

  • 30. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease.
    O'Donoghue DJ; Short CD; Brenchley PE; Lawler W; Ballardie FW
    Clin Nephrol; 1989 Dec; 32(6):251-5. PubMed ID: 2612068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis.
    Jayne DR; Weetman AP; Lockwood CM
    Clin Exp Immunol; 1991 Jun; 84(3):476-81. PubMed ID: 2044229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-cytoplasmic antibodies of polynucle or "ANCA". A new class of autoantibodies].
    Noël LH
    Rev Prat; 1992 Jun; 42(12):1534-9. PubMed ID: 1411180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The autoimmune basis of ANCA positive systemic vasculitis.
    Oliveira DB; Lockwood CM
    Ann Med Interne (Paris); 1992; 143(6):396-8. PubMed ID: 1295393
    [No Abstract]   [Full Text] [Related]  

  • 34. Late emergence of systemic vasculitis with anti-neutrophil cytoplasmic antibodies in a dialyzed patient with anti-glomerular basement glomerulonephritis.
    Vanhille P; Noel LH; Reumaux D; Fleury D; Lemaitre V; Gobert P
    Clin Nephrol; 1990 May; 33(5):257-8. PubMed ID: 2354567
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognosis of vasculitis associated myelodysplasia.
    Belizna C; Subra JF; Henrion D; Ghali A; Renier G; Royer M; Corre YL; Martin L; Voswinkel J; Ifrah N
    Autoimmun Rev; 2013 Aug; 12(10):943-6. PubMed ID: 23542504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 1992 Feb; 4(1):9-15. PubMed ID: 1543669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatic manifestations of the myelodysplastic syndromes: a comparative study.
    Chandran G; Ahern MJ; Seshadri P; Coghlan D
    Aust N Z J Med; 1996 Oct; 26(5):683-8. PubMed ID: 8958365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA).
    Falk RJ; Hogan SL; Wilkman AS; Terrell RS; Lauritzen S; Charles LA; Jennette JC
    Neth J Med; 1990 Apr; 36(3-4):121-5. PubMed ID: 2162486
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis have the same target specificity.
    Harrison DJ; Kharbanda R
    J Pathol; 1989 Jul; 158(3):233-8. PubMed ID: 2671323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes.
    Wiik A
    Mod Rheumatol; 2009; 19(6):590-9. PubMed ID: 19730973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.